Both showed a pro-autophagic effect mediated by the mTOR/LC3/p62/BECN1 signaling pathway and reduced the migration of HER2-positive SK-BR-3 breast cancer cells through the integrin β1/FAK/paxillin pathway [119]. The gene discussed is ERBB2; the disease is breast cancer.